Form 8.5 (EPT/NON-RI) - Spire Healthcare Group plc

Summary by AI BETAClose X

J.P. Morgan SE, acting as corporate broker to Spire Healthcare Group plc, disclosed on 04 November 2026 that as at 03 November 2026 it held 23,322 1p ordinary shares (0.01%) and short positions of 1,297 shares (0.00%); it purchased 18,413 shares at prices between £2.4812 and £2.4850 and sold 19,710 shares at £2.4843; no cash-settled or stock-settled derivatives, no subscription rights, and no indemnity or other dealing arrangements were reported, and no Supplemental Form 8 (Open Positions) was attached.

Disclaimer*

UK 100

Latest directors dealings